PRPH

ProPhase Labs Inc.

Price

$0.007500

return (12m)

-99.79%

p/e

0.00

p/bv

-0.15

DIVIDEND YIELD

0.00%

PRPH price

ProPhase Labs

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment PRPH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-27.18%

3 months

-81.25%

1 year

-99.79%

2 years

-99.96%

5 years

-99.99%

10 years

-99.92%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PRPH

Valuation

P/E

0.00

Sector -3.16

Industry -3.16

P/BV

-0.15

Sector 1.80

Industry 1.80

P/Revenue (PSR)

0.02

Sector 2.04

Industry 2.04

EV/EBITDA

-0.01

Sector -204.34

Industry -204.34

EV/EBIT

0.00

Sector -42.58

Industry -42.58

P/EBITDA

-0.01

Sector -19.73

Industry -19.73

P/EBIT

-0.01

Sector -67.09

Industry -67.09

P/Total Assets

0.00

Sector 1.06

Industry 1.06

P/Net Current Assets

0.00

Sector -9.56

Industry -9.56

P/Working Capital

0.00

Sector -93.82

Industry -93.82

EPS

-1.99

Sector -1.78

Industry -1.78

BVPS

-0.05

Sector 1.99

Industry 1.99

Efficiency

Gross Margin

28.43%

Sector 41.28%

Industry 41.28%

EBITDA Margin

-187.18%

Sector -21,198.78%

Industry -21,198.78%

EBIT Margin

-100.00%

Sector -35.28%

Industry -35.28%

Net Profit Margins

-100.00%

Sector -35.71%

Industry -35.71%

Asset Turnover

0.02

Sector 0.03

Industry 0.03

Profitability

ROE

-329.15%

Sector -61.32%

Industry -61.32%

ROA

-43.88%

Sector -54.29%

Industry -54.29%

ROIC

-14.33%

Sector -1,801.33%

Industry -1,801.33%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.06

Sector 2.91

Industry 2.91

Net Debt / EBITDA

0.00

Sector -20.38

Industry -20.38

Net Debt / EBIT

0.00

Sector -4.13

Industry -4.13

Net Debt / Equity

0.05

Sector -33,112.98

Industry -33,112.98

Gross Debt / Equity

0.00

Sector -0.64

Industry -0.64

Equity/Assets

-0.01

Sector 0.46

Industry 0.46

Liabilities/Assets

1.01

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

-44.72%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals PRPH

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PRPH ProPhase Labs Inc.	$0.007500	-99.79%	0.00%	0.00	-0.15	-329.15%	-100.00%
PFE Pfizer Inc.	$30.52	34.46%	5.73%	39.46	2.00	4.97%	6.80%
ABBV AbbVie Inc.	$294.89	39.56%	2.31%	53.66	0.00	-%	14.76%
NVO Novo Nordisk A/S	$40.00	-15.09%	4.66%	9.73	5.17	60.28%	35.32%
MRK Merck & Co. Inc.	$149.52	79.00%	2.27%	116.34	8.79	6.97%	4.77%
AZN AstraZeneca PLC	$186.65	15.21%	1.73%	22.38	5.77	27.27%	16.95%
BMY Bristol-Myers Squibb Company	$62.48	43.52%	5.06%	13.78	5.44	44.06%	18.47%
ZTS Zoetis Inc.	$79.72	-43.61%	2.60%	12.71	10.64	64.91%	27.69%
AMGN Amgen Inc.	$466.01	61.33%	2.13%	28.86	21.58	91.47%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$927.89	42.92%	0.41%	21.68	2.96	14.04%	27.86%
HALO Halozyme Therapeutics Inc.	$130.91	100.81%	0.00%	37.10	106.90	173.67%	24.86%
MCK McKesson Corporation	$994.58	23.18%	0.34%	25.96	-30.85	-168.45%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$558.88	31.33%	0.00%	32.22	7.01	23.54%	35.00%
CAH Cardinal Health Inc.	$250.48	32.55%	0.81%	34.74	-21.86	-63.98%	0.67%
ARGX argenx SE	$892.87	9.09%	0.00%	13.26	-	-%	25.42%
HRMY Harmony Biosciences Holdings Inc.	$38.76	35.67%	0.00%	12.39	2.25	20.46%	18.88%
BIIB Biogen Inc.	$253.62	64.40%	0.00%	45.08	2.00	4.58%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PRPH - Historical Dividends

Current Dividend Yield

0.00%

5-year average Dividend Yield

2.15%

Current Payout

—

5-year average Payout

124.32%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/23/2022	06/03/2022	3.00000000
Dividends	02/25/2022	03/10/2022	3.00000000
Dividends	05/21/2021	06/03/2021	3.00000000
Dividends	11/29/2019	12/12/2019	2.50000000
Dividends	01/08/2019	01/24/2019	2.50000000
Dividends	05/17/2018	06/05/2018	9.26300000
Dividends	05/17/2018	06/05/2018	10.00000000

ABOUT ProPhase Labs

ProPhase Labs Inc.

Average Investor10 user rating

4.0 (0 people)

United States

37 years

Founded: 1989

1995

Time since IPO - 31 years

95

Employees

ProPhase Labs Inc. (United States) is listed on the Nasdaq and has a market capitalization of $90.00 Thousand, with shareholders equity totaling $-610.00 Thousand.

The company employs approximately 95 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ProPhase Labs Inc. reported $4.08 million in revenue, generating net income of $-23.88 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of -0.15, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PRPH.

Market cap

$90.00 Thousand

Net worth

$-610.00 Thousand

$-610,000.00

Assets

$58.73 million

$58,730,000.00

Total Shares Outstanding

12.00 million

12,000,000

Average Daily Trading Volume

$341.22 Thousand

$341,223.24

Sector

Health Care

Industry

Biotechnology

PRPH

PRPH revenue and profits

Financial Results PRPH

DRAG THE FRAME TO SEE MORE DATA

PRPH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$994.58 23,18% (12M)

P/E

25.96

0.34%

ROE

-168.45%

P/BV

-30.85

CAH - Cardinal Health

$250.48 32,55% (12M)

P/E

34.74

0.81%

ROE

-63.98%

P/BV

-21.86

ABBV - AbbVie

$294.89 39,56% (12M)

P/E

53.66

2.31%

ROE

P/BV

0.00

MRK - Merck & Co.

$149.52 79,00% (12M)

P/E

116.34

2.27%

ROE

6.97%

P/BV

8.79

AZN - AstraZeneca

$186.65 16,17% (12M)

P/E

22.38

1.73%

ROE

27.27%

P/BV

5.77

PFE - Pfizer

$30.52 34,46% (12M)

P/E

39.46

5.73%

ROE

4.97%

P/BV

2.00

BMY - Bristol-Myers Squibb

$62.48 43,52% (12M)

P/E

13.78

5.06%

ROE

44.06%

P/BV

5.44

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$994.58 23,18% (12 M)

P/L

25.96

0.34%

ROE

-168.45%

P/VP

-30.85

CAH - Cardinal Health

$250.48 32,55% (12 M)

P/L

34.74

0.81%

ROE

-63.98%

P/VP

-21.86

ABBV - AbbVie

$294.89 39,56% (12 M)

P/L

53.66

2.31%

ROE

P/VP

0.00

MRK - Merck & Co.

$149.52 79,00% (12 M)

P/L

116.34

2.27%

ROE

6.97%

P/VP

8.79

AZN - AstraZeneca

$186.65 16,17% (12 M)

P/L

22.38

1.73%

ROE

27.27%

P/VP

5.77

PFE - Pfizer

$30.52 34,46% (12 M)

P/L

39.46

5.73%

ROE

4.97%

P/VP

2.00

BMY - Bristol-Myers Squibb

$62.48 43,52% (12 M)

P/L

13.78

5.06%

ROE

44.06%

P/VP

5.44

Frequently Asked Questions

What is the price of ProPhase Labs (PRPH) today?

The current price of ProPhase Labs (PRPH) is $0.007500. The stock began the year trading around $0.45 and is currently priced at $0.007500. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does ProPhase Labs (PRPH) pay dividends?

ProPhase Labs (PRPH) did not pay dividends over the past year.

Is ProPhase Labs (PRPH) a good investment?

ProPhase Labs (PRPH) is currently trading at $0.007500 with a P/E ratio of 0.00. This represents a 90% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -99.79%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ProPhase Labs (PRPH) stock?

You can buy ProPhase Labs (PRPH) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol PRPH and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of ProPhase Labs (PRPH) yield today?

Over the past month, ProPhase Labs (PRPH) has returned -27.18% — -99.79% over the past year, and -99.99% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of ProPhase Labs (PRPH) today at the current price of $0.007500 your total investment would be $0.75.

Based on historical performance, the investment would have grown to approximately:

$0.001575 after 1 year
$0.000075 after 5 years
$0.000600 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PRPH

ProPhase Labs Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PRPH

Target price created!

Delete target price?

Your Target Price strategy deserves unlimited alerts

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PRPH WITH OTHER STOCKS

type

Ex - Dividend Date

payment date

value

ABOUT ProPhase Labs

ProPhase Labs Inc.

United States

37 years

1995

95

PROFIT X PRICE PRPH

Financial Results PRPH

PRPH cash flow

Asset, Revenue and Profit Growth - PRPH

PRPH balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BMY - Bristol-Myers Squibb

Frequently Asked Questions